News | January 12, 2023
H.B. Fuller to launch new bio-compatible adhesive for medical applications
Swiftmelt 1515-I meets performance requirements and secures skin attachment
Swiftmelt 1515-I meets performance requirements and secures skin attachment
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
The JUST 100 is the only ranking that recognizes companies doing right by all their stakeholders as defined by the American public.
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
International Business is expected to post double-digit revenue growth during the quarter in constant currency.
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
Subscribe To Our Newsletter & Stay Updated
